Skip to content
TrialScanner

NCT04541225

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Phase 1TerminatedNUVBLead

Registry record

Lead sponsor
Nuvation Bio Inc.
Conditions
Glioma; Glioma, Malignant; Glioma, Mixed; Glial Cell Tumors; Breast Cancer
Primary completion
Aug 31, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04541225 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04541225: Study of NUV-422 in Adults... | TrialScanner